论文部分内容阅读
目的探究糖尿病足溃疡患者应用外用碱性成纤维细胞生长因子联合超短波治疗的效果分析。方法选取该院2016年2月—2017年2月期间接收的糖尿病足溃疡患者74例作为该次研究的对象,按照治疗方式上的差异随机分为两组,对照组采用常规血糖控制及抗感染治疗,而研究组则采用外用碱性成纤维细胞生长因子联合超短波治疗,对比两组临床疗效。结果研究组治疗7 d后,患者的各项临床症状评分均优于对照组;而治疗3个疗程之后,患者的治疗总有效率明显高于对照组(P<0.05)。结论在糖尿病足溃疡患者采用外用碱性成纤维细胞生长因子联合超短波治疗,不仅近期疗效显著,而且能够取得良好的远期疗效,有效改善患者的各项临床症状,值得大力推广与应用。
Objective To investigate the effect of external application of basic fibroblast growth factor combined with ultrashort wave therapy in patients with diabetic foot ulcer. Methods Totally 74 patients with diabetic foot ulcer received during the period from February 2016 to February 2017 in the hospital were selected as the subjects and randomly divided into two groups according to the differences in treatment methods. The control group received routine blood glucose control and anti-infection Treatment, while the study group is the use of topical fibroblast growth factor combined with ultrashort wave treatment, the clinical efficacy of two groups were compared. Results After 7 days of treatment, all the clinical symptom scores in the study group were better than those in the control group. After three courses of treatment, the total effective rate of the treatment group was significantly higher than that of the control group (P <0.05). Conclusion The treatment of diabetic foot ulcer by external use of basic fibroblast growth factor combined with ultrashortwave, not only the short-term effect is significant, and can achieve good long-term efficacy, effectively improve the clinical symptoms of patients, it is worth to promote and application.